BODY Latest Quarter's Earnings
| Announce Date | 03/11/2024 |
| EPS Normalized Actual | $-10.4246 (Miss by $-8.1746) |
| EPS GAAP Actual | $-10.4246 (Miss by $-8.1746) |
| Revenue Actual | $0.110183B |
| Revenue Surprise | Beat by $110.183M |
Upcoming Quarter's Earnings
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
Annual EPS Estimate
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2024 | -0.19 | -42.84 | -0.19 | -0.19 | 1 |
| Dec 2023 | -0.3 | -27.13 | -0.3 | -0.3 | 2 |
Quarterly EPS History
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2024 (Jun 2024) | -1.59 | -2.93259 | 0.110183B | -22.48% | -159.71M |
| FQ3 2024 (Sep 2024) | -1.75 | -3.29141 | 0.102193B | -25.5% | -201.44M |
| FQ4 2024 (Dec 2024) | 0.1 | 0.1 | 0.036588B | -225.27% | 36.59M |
| FQ1 2025 (Mar 2025) | -0.84 | -0.84 | 0.072363B | 100% | 72.36M |
| FQ4 2023 (Dec 2023) | -10.42 | -10.34 | 0.11901B | -24.5% | 0.69M |
| FQ3 2023 (Sep 2023) | -0.11 | -0.04 | 0.12825B | -29.42% | 1.18M |
| FQ2 2023 (Jun 2023) | -0.0819 | -0.0219 | 0.134948B | -32.74% | -1.31M |
| FQ1 2023 (Mar 2023) | -0.0944 | -0.0344 | 0.144901B | 100% | 6.22M |
Quarterly Estimates Summary
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Consensus EPS Estimates
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|
Consensus Revenue Estimates
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|
Quarterly Estimates Revisions
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Consensus EPS Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Consensus Revenue Revision Trend
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Earnings Surprise Summary
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
5
Revenue # of Misses
3
Revenue # of in-lines
0
Earnings Surprise (EPS) - Actual vs Consensus
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2024 (Jun 2024) | 1.34259 | -1.59 | -2.93259 | 184.44% |
| FQ3 2024 (Sep 2024) | 1.54141 | -1.75 | -3.29141 | 188.08% |
| FQ4 2024 (Dec 2024) | 0.1 | 0.1 | 100% | |
| FQ1 2025 (Mar 2025) | -0.84 | -0.84 | 100% | |
| FQ4 2023 (Dec 2023) | -0.08 | -10.42 | -10.34 | 99.23% |
| FQ3 2023 (Sep 2023) | -0.07 | -0.11 | -0.04 | 36.36% |
| FQ2 2023 (Jun 2023) | -0.06 | -0.0819 | -0.0219 | 26.74% |
| FQ1 2023 (Mar 2023) | -0.06 | -0.0944 | -0.0344 | 36.44% |
Revenue Surprise - Actual vs Consensus
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2024 (Jun 2024) | $0.27B | $0.11B | $-159.71M | -144.95% |
| FQ3 2024 (Sep 2024) | $0.3B | $0.1B | $-201.44M | -197.12% |
| FQ4 2024 (Dec 2024) | $0B | $0.04B | $36.59M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.07B | $72.36M | 100% |
| FQ4 2023 (Dec 2023) | $0.12B | $0.12B | $0.69M | 0.58% |
| FQ3 2023 (Sep 2023) | $0.13B | $0.13B | $1.18M | 0.92% |
| FQ2 2023 (Jun 2023) | $0.14B | $0.13B | $-1.31M | -0.97% |
| FQ1 2023 (Mar 2023) | $0.14B | $0.14B | $6.22M | 4.29% |
BODY Ratings Summary
BODY Quant Ranking
